Patent · US Active

siRNA silencing of filovirus gene expression

US7838658B2 · kind B2 · utility

66Cited by
8References
45Claims
0Family size

Inventors

Key dates

Filing dateOct 20, 2006
Grant dateNov 23, 2010
Priority date
Expiry dateDec 4, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene expression. The present invention also provides nucleic acid-lipid particles that target Filovirus gene expression comprising an siRNA that silences Filovirus gene expression, a cationic lipid, and a non-cationic lipid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.